Summit Therapeutics SMMT Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $14.7B.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's market capitalization?
- Summit Therapeutics (SMMT) reported market capitalization of $14.7B in Q1 2026.
- How has Summit Therapeutics's market capitalization changed year-over-year?
- Summit Therapeutics's market capitalization increased by 3.3% year-over-year, from $14.23B to $14.7B.
- What is the long-term trend for Summit Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), Summit Therapeutics's market capitalization has grown at a 31.6% compound annual growth rate (CAGR), from $3.3B to $13.02B.
- What does market capitalization mean?
- What the stock market says the company's equity is worth.
- How do you interpret market capitalization?
- A size and market-sentiment gauge, not a quality measure — interpret through valuation ratios (P/E, P/S) that relate it to fundamentals.
- How does market capitalization compare across companies?
- Comparable across companies as a size class; the input to every equity-price valuation multiple.